| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 18,263 | | Cost of Revenue |
-
| | | Gross Profit | 18,263 | | | Operating Expenses | | Research Development | 151,276 | | Selling General and Administrative | 46,339 | | Non Recurring | (19,299) | | Others |
-
| | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | (160,053) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 29 | | Earnings Before Interest And Taxes | (160,024) | | Interest Expense | 1,708 | | Income Before Tax | (161,732) | | Income Tax Expense | 81 | | Minority Interest |
-
| | | | Net Income From Continuing Ops | (161,813) | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | (161,813) | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | ($161,813) |
|
0.34% Nasdaq 0.00%
Income Statement
